Nuss John's Form 4 filing
Ventyx Biosciences, Inc. (VTYX) · filed Oct 4, 2023
- Accession no.
- 0001209191-23-052120
- Filed
- Oct 4, 2023, 7:26 PM ET
- Trade date
- Oct 3, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $299.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nuss JohnCIK 0001874108 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 3, 2023 | Common Stock | MOption exerciseAcquired | +1,401 | $0.20 | +$280.2 | 246,216 | Direct | |
| Oct 3, 2023 | Common Stock | MOption exerciseAcquired | +7,972 | $3.54 | +$28,220.88 | 254,188 | Direct | |
| Oct 3, 2023 | Common Stock | MOption exerciseAcquired | +627 | $8.04 | +$5,041.08 | 254,815 | Direct | |
| Oct 3, 2023 | Common Stock | SSaleDisposed | −9,277 | $29.94F2 | −$277,725.55 | 245,538 | Direct | |
| Oct 3, 2023 | Common Stock | SSaleDisposed | −723 | $30.72F3 | −$22,207.31 | 244,815 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 3, 2023 | Common Stock | MOption exerciseDisposed | −1,401 | $0.00 | $0 | 5,377 | Direct | |
| Oct 3, 2023 | Common Stock | MOption exerciseDisposed | −7,972 | $0.00 | $0 | 0 | Direct | |
| Oct 3, 2023 | Common Stock | MOption exerciseDisposed | −627 | $0.00 | $0 | 192,777 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 9,277 shares sold in the price range of $29.24 to $30.205. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average share price of an aggregate total of 723 shares sold in the price range of $30.255 to $30.965. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.